French sales subsidiary of Japanese pharma firm Eisai divests rights of neurology drugs for € 56.5 M
Europe | News | 0 Comment | 09 Apr, 2024
Japan headquartered pharma company Eisai Co. has announced that its French sales subsidiary Eisai S.A.S. has entered int...Read more
Japan's NS Pharma & UK-based MiNA Therapeutics lay focus on rare diseases of Central Nervous System
Europe | News | 0 Comment | 04 Apr, 2024
NS Pharma, Inc. has announced that its parent company, Nippon Shinyaku Co., headquartered in Kyoto, Japan, has ente...Read more
Europe | News | 0 Comment | 27 Mar, 2024
Polyplus (part of Sartorius, a distinguished upstream solutions provider for biologic and cell and gene the...Read more
Korean startup Lunit delivers AI-powered cancer screening solution to France and Portugal
Europe | News | 0 Comment | 18 Mar, 2024
Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has...Read more
TFS HealthScience establishes operation in Australia expanding its CRO capabilities to APAC
Europe | News | 0 Comment | 12 Mar, 2024
TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), has expanded into the Asia Pacific&...Read more
New ‘spin freezing’ technique to enhance future mRNA vaccines
Europe | News | 0 Comment | 12 Mar, 2024
A top-ranking public research university in Belgium has received funding from Norway-based Coalition for Epidemic Prepar...Read more
Polyplus expands GMP offer with protein production and adds GMP capacity in Belgium
Europe | News | 0 Comment | 06 Mar, 2024
Polyplus (part of Satorius) company, Xpress Biologics, has received a good manufacturing practice (GMP) c...Read more
First ever large-scale GMP manufacturing of therapeutic IgE antibody achieved in the UK
Europe | News | 0 Comment | 05 Mar, 2024
Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...Read more
Medigene AG expands patent portfolio in Japan for iM-TCR Technology
Europe | News | 0 Comment | 04 Mar, 2024
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapie...Read more
Japan's Daiichi Sankyo invests €1B in Germany site, expanding into innovation centre
Europe | News | 0 Comment | 29 Feb, 2024
With investments of approximately one billion euros, Japan headquartered Daiichi Sankyo will expand its production and ...Read more
Eppendorf Innovation Company strengthens access to US startup scene
Europe | News | 0 Comment | 14 Feb, 2024
The Eppendorf Innovation Company (EpIC) – a division of Eppendorf SE – continues to expand its interna...Read more
Takeda, Dundee and Cambridge reunite in fight against dementia
Europe | News | 0 Comment | 14 Feb, 2024
UK-based University of Dundee’s Drug Discovery Unit has announced a renewed partnership with Japanese pharmaceut...Read more
SGD Pharma Launches Type I Vials with Corning's Velocity® Coating
Europe | News | 0 Comment | 05 Feb, 2024
SGD Pharma, global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces ...Read more
SGD Pharma expands capacity of siliconised glass vials for pharma packaging in France
Europe | News | 0 Comment | 23 Jan, 2024
SGD Pharma has announced the opening of a new siliconisation operation at its state-of-the-art Saint-Quentin Lamott...Read more
VirtualiSurg Mediverse accelerates training for surgery and health-tech sectors globally
Europe | News | 0 Comment | 17 Jan, 2024
Paris-headquartered international medtech firm, VirtualiSurg has created an immersive mediverse – a virtual learni...Read more
Merck expands colorectal cancer portfolio through licensing agreement with Inspirna for $45 M
Europe | News | 0 Comment | 05 Jan, 2024
Merck, a leading science and technology company, has announced a licensing agreement with US-based firm Inspirna, Inc. f...Read more
Roche buys LumiraDx’s Point-of-Care technology for more than $300 M
Europe | News | 0 Comment | 31 Dec, 2023
Swiss firm Roche has announced the entry into a definitive agreement to acquire select parts of the UK-based LumiraDx gr...Read more
Europe | News | 0 Comment | 18 Dec, 2023
Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...Read more